Loss-of-function somatic alterations of the SMAD4 gene have been linked to a wide range of tumor types, including pancreatic, colorectal, gastric, breast, and thyroid cancer, and germline genetic alterations, which have been associated with JPS [37,38,39,40,41]. This evidence concerns the gene SMAD4 and thyroid gland carcinoma.